Hanmi Pharm: back-to-back technology export deals overshadow management dispute with strong core business
Predicted impact: Medium
Fabry drug export worth about 38% of revenue was already reported recently.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.